Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
11,764,939
-
Total 13F shares
-
75,674
-
Share change
-
+3
-
Total reported value
-
$58,764
-
Price per share
-
$1.00
-
Number of holders
-
7
-
Value change
-
+$3
-
Number of buys
-
3
Institutional Holders of Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA) as of Q1 2023
As of 31 Mar 2023,
Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA) was held by
7 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
75,674 shares.
The largest 7 holders included
McAdam, LLC, Amplius Wealth Advisors, LLC, Federation des caisses Desjardins du Quebec, SIGNATUREFD, LLC, HARBOR INVESTMENT ADVISORY, LLC, Allworth Financial LP, and WELLS FARGO & COMPANY/MN.
This page lists
7
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.